Issue |
Section |
Title |
File |
Vol 81, No 7 (2009) |
Editorial |
Results of the treatment of adult acute lymphoblastic leukemia according to ALL-2005 protocol as a basis for new trials |
|
Vol 83, No 3 (2011) |
Editorial |
Development of acute myeloid leukemia from donor cells after allogenic peripheral blood stem cell transplantation in a female patient with acute monoblastic leukemia |
|
Vol 83, No 7 (2011) |
Editorial |
Extremely high concentration of mexotrexate in blood serum leading to development of acute renal failure in a patient with acute lymphoblastic leukemia after high-dose consolidation |
|
Vol 90, No 7 (2018) |
Editorial |
Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation |
 (Rus)
|
Vol 90, No 7 (2018) |
Editorial |
Diagnostics and treatment challenges of Ph-like acute lymphoblastic leukemia: a description of 3 clinical cases |
 (Rus)
|
Vol 91, No 8 (2019) |
Editorial |
Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation |
 (Rus)
|
Vol 92, No 7 (2020) |
Original articles |
Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways |
 (Rus)
|
Vol 93, No 7 (2021) |
Editorial |
Development of program therapy for patients with acute myeloid leukemia under the age of 60 years, based on the principles of differentiated effects |
 (Rus)
|
Vol 93, No 7 (2021) |
Original articles |
Li–Fraumeni syndrome in adult patients with acute lymphoblastic leukemia |
 (Rus)
|